These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 29019968)

  • 1. Fighting the fatty liver.
    Drew L
    Nature; 2017 Oct; 550(7675):S102-S103. PubMed ID: 29019968
    [No Abstract]   [Full Text] [Related]  

  • 2. Managing non-alcoholic fatty liver disease in diabetes: Challenges and opportunities.
    Lee CH; Lam KS
    J Diabetes Investig; 2017 Mar; 8(2):131-133. PubMed ID: 27181498
    [No Abstract]   [Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease as a multi-systemic disease.
    Fotbolcu H; Zorlu E
    World J Gastroenterol; 2016 Apr; 22(16):4079-90. PubMed ID: 27122660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-alcoholic fatty liver: position document of the Catalan Society of Gastroenterology].
    Caballería L; Saló J; Berzigotti A; Planas R; Vila C; Huertas C; Torres M; Torán P; Caballería J;
    Gastroenterol Hepatol; 2014; 37(6):372-83. PubMed ID: 24746904
    [No Abstract]   [Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease and type 2 diabetes: common pathophysiologic mechanisms.
    Saponaro C; Gaggini M; Gastaldelli A
    Curr Diab Rep; 2015 Jun; 15(6):607. PubMed ID: 25894944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and reduced metabolic flexibility: cause or consequence of NAFLD?
    Gastaldelli A
    Clin Sci (Lond); 2017 Nov; 131(22):2701-2704. PubMed ID: 29109303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum 25-hydroxyvitamin D, non-alcoholic fatty liver disease and type 2 diabetes.
    Afarideh M; Ghajar A; Noshad S; Saadat M; Khajeh E; Esteghamati A
    Nutr Metab Cardiovasc Dis; 2017 Jan; 27(1):93-95. PubMed ID: 27986351
    [No Abstract]   [Full Text] [Related]  

  • 8. An update on nonalcoholic fatty liver disease.
    Provencher DM
    JAAPA; 2014 Jul; 27(7):18-22. PubMed ID: 24901731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-alcoholic fatty liver disease (NAFLD)].
    Rau M; Weiss J; Geier A
    Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADV36 adipogenic adenovirus in human liver disease.
    Trovato FM; Catalano D; Garozzo A; Martines GF; Pirri C; Trovato GM
    World J Gastroenterol; 2014 Oct; 20(40):14706-16. PubMed ID: 25356033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
    Alkassabany YM; Farghaly AG; El-Ghitany EM
    Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.
    Athyros VG; Tziomalos K; Katsiki N; Doumas M; Karagiannis A; Mikhailidis DP
    World J Gastroenterol; 2015 Jun; 21(22):6820-34. PubMed ID: 26078558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum.
    Patel YA; Imperial JC; Muir AJ; Anstee QM; DeBrota D; Dimick-Santos L; Filozof C; Mehta R; Sanyal AJ; Schabel E; Neuschwander-Tetri BA; Miller V;
    Gastroenterology; 2017 Sep; 153(3):621-625.e7. PubMed ID: 28757264
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-Invasive Diagnosis of Nonalcoholic Fatty Liver Disease.
    Yoneda M; Imajo K; Nakajima A
    Am J Gastroenterol; 2018 May; 113(10):1409-1411. PubMed ID: 29937542
    [No Abstract]   [Full Text] [Related]  

  • 17. The portrait of an adult liver transplant recipient in the United States from 1987 to 2013.
    Stepanova M; Wai H; Saab S; Mishra A; Venkatesan C; Younossi ZM
    JAMA Intern Med; 2014 Aug; 174(8):1407-9. PubMed ID: 24978860
    [No Abstract]   [Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?
    Valenti L; Bugianesi E; Pajvani U; Targher G
    Liver Int; 2016 Nov; 36(11):1563-1579. PubMed ID: 27276701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.
    ; Lonardo A; Bellentani S; Argo CK; Ballestri S; Byrne CD; Caldwell SH; Cortez-Pinto H; Grieco A; Machado MV; Miele L; Targher G
    Dig Liver Dis; 2015 Dec; 47(12):997-1006. PubMed ID: 26454786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.